These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15033336)

  • 1. Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway.
    Gubellini P; Centonze D; Tropepi D; Bernardi G; Calabresi P
    Neuropharmacology; 2004 May; 46(6):761-9. PubMed ID: 15033336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine.
    Calabresi P; Gubellini P; Picconi B; Centonze D; Pisani A; Bonsi P; Greengard P; Hipskind RA; Borrelli E; Bernardi G
    J Neurosci; 2001 Jul; 21(14):5110-20. PubMed ID: 11438586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.
    Akopian G; Crawford C; Beal MF; Cappelletti M; Jakowec MW; Petzinger GM; Zheng L; Gheorghe SL; Reichel CM; Chow R; Walsh JP
    J Neurosci; 2008 Sep; 28(38):9585-97. PubMed ID: 18799690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease.
    Calabresi P; Centonze D; Pisani A; Bernardi G
    Exp Neurol; 1999 Jul; 158(1):97-108. PubMed ID: 10448421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
    Picconi B; Passino E; Sgobio C; Bonsi P; Barone I; Ghiglieri V; Pisani A; Bernardi G; Ammassari-Teule M; Calabresi P
    Neurobiol Dis; 2006 Apr; 22(1):143-52. PubMed ID: 16326108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
    Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
    J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
    Colle D; Santos DB; Moreira EL; Hartwig JM; dos Santos AA; Zimmermann LT; Hort MA; Farina M
    PLoS One; 2013; 8(6):e67658. PubMed ID: 23799154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid.
    Akashiba H; Ikegaya Y; Nishiyama N; Matsuki N
    J Biol Chem; 2008 Mar; 283(10):6594-606. PubMed ID: 18182390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
    Garcia M; Vanhoutte P; Pages C; Besson MJ; Brouillet E; Caboche J
    J Neurosci; 2002 Mar; 22(6):2174-84. PubMed ID: 11896157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum.
    Calabresi P; Saulle E; Marfia GA; Centonze D; Mulloy R; Picconi B; Hipskind RA; Conquet F; Bernardi G
    Mol Pharmacol; 2001 Oct; 60(4):808-15. PubMed ID: 11562444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.
    Le Vasseur M; Ran I; Lacaille JC
    Neuroscience; 2008 Jan; 151(1):28-42. PubMed ID: 18035501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway.
    Jamwal S; Kumar P
    Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticostriatal LTP requires combined mGluR1 and mGluR5 activation.
    Gubellini P; Saulle E; Centonze D; Costa C; Tropepi D; Bernardi G; Conquet F; Calabresi P
    Neuropharmacology; 2003 Jan; 44(1):8-16. PubMed ID: 12559117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptor 1 (mGluR1) and 5 (mGluR5) regulate late phases of LTP and LTD in the hippocampal CA1 region in vitro.
    Neyman S; Manahan-Vaughan D
    Eur J Neurosci; 2008 Mar; 27(6):1345-52. PubMed ID: 18364018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins.
    Mendoza E; Miranda-Barrientos JA; Vázquez-Roque RA; Morales-Herrera E; Ruelas A; De la Rosa G; Flores G; Hernández-Echeagaray E
    Neuroscience; 2014 Nov; 280():156-70. PubMed ID: 25241069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease.
    Marti M; Mela F; Ulazzi L; Hanau S; Stocchi S; Paganini F; Beani L; Bianchi C; Morari M
    Eur J Neurosci; 2003 Aug; 18(4):759-67. PubMed ID: 12925002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.
    Akopian G; Crawford C; Petzinger G; Jakowec MW; Walsh JP
    Neuroscience; 2012 Jul; 215():149-59. PubMed ID: 22554779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum.
    Centonze D; Prosperetti C; Barone I; Rossi S; Picconi B; Tscherter A; De Chiara V; Bernardi G; Calabresi P
    Exp Neurol; 2006 Dec; 202(2):470-9. PubMed ID: 16919272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease.
    Dalbem A; Silveira CV; Pedroso MF; Breda RV; Werne Baes CV; Bartmann AP; da Costa JC
    Brain Res; 2005 Jun; 1047(2):148-58. PubMed ID: 15901483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
    Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.